Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: The GnRH receptor

Jo Ann Janovick, Akshay Patny, Ralph Mosley, Mark T. Goulet, Michael D. Altman, Thomas S. Rush, Anda Cornea, P. Michael Conn

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


The human GnRH receptor (hGnRHR), a G protein-coupled receptor, is a useful model for studying pharmacological chaperones (pharmacoperones), drugs that rescue misfolded and misrouted protein mutants and restore them to function. This technique forms the basis of a therapeutic approach of rescuing mutants associated with human disease and restoring them to function. The present study relies on computational modeling, followed by site-directed mutagenesis, assessment of ligand binding, effector activation, and confocal microscopy. Our results show that two different chemical classes of pharmacoperones act to stabilize hGnRHR mutants by bridging residues D 98 and K 121. This ligand-mediated bridge serves as a surrogate for a naturally occurring and highly conserved salt bridge (E 90-K 121) that stabilizes the relation between transmembranes 2 and 3, which is required for passage of the receptor through the cellular quality control system and to the plasma membrane. Our model was used to reveal important pharmacophoric features, and then identify a novel chemical ligand, which was able to rescue a D 98 mutant of the hGnRHR that could not be rescued as effectively by previously known pharmacoperones.

Original languageEnglish (US)
Pages (from-to)157-168
Number of pages12
JournalMolecular Endocrinology
Issue number2
StatePublished - Feb 2009
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology


Dive into the research topics of 'Molecular mechanism of action of pharmacoperone rescue of misrouted GPCR mutants: The GnRH receptor'. Together they form a unique fingerprint.

Cite this